Clinical trial

JUR-003 in Adult Patients With Metastatic Prostate Cancer

NCT07824349

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE1

Study timeline

Study start (estimated)2026-09-01Date precision: month

Registry last updated2026-10-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration Resistant Prostate Cancerunresolved

Oligometastatic Prostate Cancer (OMPC)unresolved

Metastatic Hormone Sensitive Prostate Cancerunresolved

Interventions

JUR-003BIOLOGICAL

Sponsors & collaborators

Juri Biosciences, Inc.lead sponsor

Mapped research locations

NashvilleTennessee, United States1 Grand RapidsMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07824349 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.